381 A phase I study of BAY 43-90006, a novel Raf kinase and...

381 A phase I study of BAY 43-90006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced solid tumors

A. Awada, A. Hendlisz, T. Gil, B. Schwartz, S. Bartholomeus, E. Brendel, D. de Valeriola, C. Haase, T. Delaunoit, M. Piccart
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80388-4
File:
PDF, 147 KB
english, 2004
Conversion to is in progress
Conversion to is failed